RNF2 and Neurodevelopmental delay: Consistent with the intolerance of RNF2 to LOF, NDD or cancer substitutions did not exhibit the most pathogenic VES of −20.00, highlighting the contribution of hypomorphic RNF2 missense variants to the pathology of NDDs and cancer (Fig. 1E).